| ²é¿´: 2190 | »Ø¸´: 5 | ||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | ||
yunyun89623½ð³æ (СÓÐÃûÆø)
|
[ÇóÖú]
ÇëÎÊ´ó¼ÒÈçºÎÏÂÔØ¹úÍâµÄҽѧָÄÏÄØ£¿¿ìÀ´°ï°ï°¡£¬ÔÚÏߵȰ¡~~~
|
|
|
ÇëÎÊÈçºÎÏÂÔØ¹úÍâµÄҽѧָÄϰ¡£¿ÄĸöÍøÖ·ÉÏÓÐѽ£¬ÎÒÏëÏÂ2012ACRÍ´·çÖÎÁÆÖ¸ÄÏ(ACRÖ¸ÄÏ)£ºDinesh Khanna, Jhon D. Fitzgerald, Puja P. Khanna, etal. 2012 American college of rheumatology guidelines for management of gout. Part 1: Systemic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care & research. 2012,64(10):1431-1446. Dinesh Khanna, Puja P. Khanna, John D. Fitzgerald, et al. 2012 American college of rheumatology guidelines for management of gout. Part 2: Therapy and anti-inflammatory prophylaxis of acute gouty arthritis. Arthritis Care & Research. 2012,64(10):1447-1461.ÄÄÀïÄÜÏÂѽ~~~Å£ÈË¿ìÀ´½â´ðÏ£¬¼±Óã¡£¡£¡ |
» ²ÂÄãϲ»¶
ҽѧ¿ÚµÄÇà»ù¿É²éÁËÂ𣿼±¡£
ÒѾÓÐ2È˻ظ´
ÎÄÏ×¼ÆÁ¿Ñ§3ÇøÌ«ÄÑÁË£¬Çó´óÉñÖ¸µ¼
ÒѾÓÐ5È˻ظ´
Ñ»·ÏµÍ³ÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ185È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
µ¥´¿ðåÕ¶¾ÒýÆðµÄ½ÇĤ½áĤÑ×£¬¾³£·´¸´£¬´ó¼Ò°ïÎÒ³ö³öÖ÷ÒâÔõô²ÅÄܲ»ÈÃËü·¸ÄØ£¿
ÒѾÓÐ8È˻ظ´
ÇëÎÊÄÄλҽÉú°ïÎÒ¿´ÏÂÄò³£¹æºÍÄÚ·ÖÃÚÆßÏîµÄ¼ì²é£¿Ð»Ð»£¡
ÒѾÓÐ14È˻ظ´
¡¾ÇóÖú¡¿ÈçºÎ¸ø´óÊó×öÐĵçͼ£¬ÏêÇéÇë½ø£¬Çë´ó¼Ò°ï°ïæ~
ÒѾÓÐ3È˻ظ´
¡¾×ÊÔ´¡¿ÓÅÐãµÄ¹úÍâҽѧÊÓÆµ,ÔÚÏßËÙ¶È¿ì
ÒѾÓÐ26È˻ظ´
¡¾ÇóÖú¡¿´ó¼Ò°ï°ï棬µÚÒ»´ÎºÍ¹úÍ⵼ʦÁªÏµ£¬ÔõôдÐŰ¡
ÒѾÓÐ3È˻ظ´

linnan0594
гæ (³õÈëÎÄ̳)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 8
- Ìû×Ó: 1
- ÔÚÏß: 21·ÖÖÓ
- ³æºÅ: 2683772
- ×¢²á: 2013-09-26
- רҵ: Ïû»¯ÏµÍ³¼²²¡ÕïÁÆÐ¼¼Êõ
5Â¥2014-09-28 22:02:54













»Ø¸´´ËÂ¥